FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/02/081023 [Registered on: 20/02/2025] Trial Registered Prospectively
Last Modified On: 18/02/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   To examine the result of Drushtiprada Varti Anjana effect in Simple Myopia 
Scientific Title of Study   A Randomised Control Clinical Trial To Evaluate The Efficacy Of Drushtiprada Varti Anjana In The Management Of Pratham Patalgat Timira W. S. R. To Simple Myopia 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Vaishnavi Shailesh Patil  
Designation  MS Shalakyantantra Scholar 
Affiliation  L K R Ayurvedic Mahavidyalay Gadhinglaj  
Address  Shalakyatantra Department 1st floor OPD no 49 Late Kedari Redekar Ayurvedic Mahavidyalay Gadhinglaj. P2 , M. I.D. C. Area, Shendri Mal ,Gandhinglaj , Kolhapur .

Kolhapur
MAHARASHTRA
416502
India 
Phone  7249645777  
Fax    
Email  psiddhesh634@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Poonam G Belgaonkar 
Designation  MS Shalakyatantra  
Affiliation  L K R Ayurvedic Mahavidyalay Gadhinglaj  
Address  Shalakyatantra department 1 st floor OPD no 49 Late Kedari Redekar Ayurvedic Mahavidyalay P.G. Gadhinglaj. P2, M.I.D.C. Shendri Mal, Gadhinglaj, Kolhapur

Kolhapur
MAHARASHTRA
416502
India 
Phone  8605657046  
Fax    
Email  Dr.poonam2785@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Vaishnavi Shailesh Patil 
Designation  MS Shalakyatantra Scholar 
Affiliation  L K R Ayurvedic Mahavidyalay Gadhinglaj  
Address  Shalakyatantra department 1 st floor OPD no 49 Late Kedari Redekar Ayurvedic Mahavidyalay P.G. Gadhinglaj. P2, M.I.D.C. Shendri Mal, Gadhinglaj, Kolhapur

Kolhapur
MAHARASHTRA
416502
India 
Phone  7249645777  
Fax    
Email  psiddhesh634@gmail.com  
 
Source of Monetary or Material Support  
L K R Ayurvedic College and Research Centre Gadhinglaj. P2 , M. l. D. C. Area, Shendri Mal, Gandhinglaj, Kolhapur. PIN code 416502 Maharashtra India 
 
Primary Sponsor  
Name  Dr Vaishnavi Shailesh Patil  
Address  Shalakyatantra department 1st floor OPD no 49 Late Kedari Redekar Ayurvedic Mahavidyalay P. G. Gandhinglaj. P2 M. I. D. C. Area, Shendri Mal, Gandhinglaj, Kolhapur, Maharashtra. PIN code 416502 India 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Poonam G Belgaonkar   L K R Ayurvedic Mahavidyalay Gadhinglaj   Shalakyatantra department 1st floor OPD no 49 Late Kedari Redekar Ayurvedic Mahavidyalay P.G. Gadhinglaj. P2, M.I.D.C. Area, Shendri Mal, Gadhinglaj, Kolhapur 416502 Maharashtra, India
Kolhapur
MAHARASHTRA 
8605657046

dr.poonam2785@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
L K R Ayurvedic Mahavidyalay Gadhinglaj   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Myopia 
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Drushtiprada varti , Reference: Gad nigrah 3rd chapter 260 th shlok, Route: Ocular, Dosage Form: Varti/ Suppository, Dose: 1(NA), Frequency: od, Bhaishajya Kal: Abhakta, Duration: 21 Days, anupAna/sahapAna: No, Additional Information: -Drushtiprada Varti Anjana will be used in patients of simple myopia in 1 Harenu dosage
2Comparator ArmDrugClassical(1) Medicine Name: Chandrodaya varti, Reference: Chakradutta 59th chapter 101 shlok, Route: Ocular, Dosage Form: Varti/ Suppository, Dose: 1(NA), Frequency: od, Bhaishajya Kal: Abhakta, Duration: 21 Days, anupAna/sahapAna: No, Additional Information: -Chandrodaya Varti Anjana will be used in patients of simple myopia in 1 Harenu dosage
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  35.00 Year(s)
Gender  Both 
Details  Patients with simple myopia with low error less than or equal to minus 3Dwith opthalmoscopic findings  
 
ExclusionCriteria 
Details  Patients of moderate myopia minus 3D to minus 6D.
Patients of high myopia greater than or equal to minus 6D.
Hypermetropia, astigmatism, presbyopia.
Axial length greater than 28
Patient with ocular pathology, cataract, glaucoma, retinopathy, corneal ulcer,conjunctivitis.  
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Pre-numbered or coded identical Containers 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Efficacy of Drushtiprada varti Anjana in simple myopia  3 weeks  
 
Secondary Outcome  
Outcome  TimePoints 
Adverse reaction if any  21 days 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   01/03/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary        This study is single blind randomized controlled clinical study to evaluate the efficacy of Drushtiprada varti Anjana in Simple myopia. 
     Total 60 patients of age 18 to 35 years of both sexes will be randomly selected for this trial and divided into two groups.
Group A - Will be treated with Drushtiprada varti Anjana.
Group B - Will be treated with Chandrodaya varti Anjana.
 
Close